- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT01861327
The Use of Carbon Dioxide as a Contrast Media for Performing Endovascular Procedures
February 23, 2017 updated by: Nelson Wolosker
Prospective randomized comparison between endovascular procedures performed with iodinated contrast or carbon dioxide as intraarterial contrast.
Study Overview
Status
Unknown
Intervention / Treatment
Detailed Description
120 patients will undergo endovascular procedures: 40 for the treatment of lower limb ischemia caused by aortoiliac stenosis classified according to the consensus for the management of peripheral arterial disease (TASC) A or B with an indication for angioplasty as the inclusion criteria; 40 for the treatment of lower limb ischemia due to stenosis femoropopliteal TASC A or B with an indication of angioplasty as the inclusion criteria and 40 for the treatment of abdominal aortic aneurysm (AAA) with indication for endovascular repair.
Of these procedures, half chosen randomly by computerized simple random, will be submitted to the endovascular procedure in question using only iodinated contrast and the other half will be submitted to the endovascular procedure using carbon dioxide (CO2).
There will be no CO2 injection in the aortic arch or cerebral territory.
The patient previously evaluated at the Hospital Municipal Dr. Moses Deutsch will be referred to the operating room of the Albert Einstein Hospital where it will be performed under general anesthesia with intubation or blockage associated with sedation, and the same in the supine position (DDH).The femoral artery will be punctured with Seldinger technique unilaterally or bilaterally, according to the indication for the procedure.
By using the guide wire will be one or two sheaths inserted in a retrograde manner.
Through the introducer, is manually injected retrogradely 50 ml of CO 2, in obtaining images of the apparatus module CO2 Philips mode subtraction angiography.
In angioplasty for obstructive disease, with the module roadmap will be held the passage of the guidewire through the stenotic region or occlusion, and dilatation balloon angioplasty specific.
After angioplasty, there will be a new injection of contrast for the evaluation of partial results.
As appropriate, will be held stent placement, in which case there will be a last angiography with 50 ml of CO2.
In endovascular repair of abdominal aortic aneurysms, there will be a first injection of CO2 for the study of the neck of the aneurysm and stent implantation.
After the release of the entire stent, a new angiography is performed by injection of CO2 for the control of surgical outcome.
In all procedures will be performed to measure pressure through the femoral sheath prior to angioplasty, after angioplasty and stent after the placement.
During the use of CO2 as contrast medium, with questions at the trial of such factors as the extent of injury, indication of repair, endoleak, leak, rupture or thrombosis by arteriography will be performed by manual injection of iodinated contrast.Of course this amount of contrast is measured.
Study Type
Interventional
Enrollment (Anticipated)
120
Phase
- Not Applicable
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Locations
-
-
SP
-
São Paulo, SP, Brazil
- Hospital Israelita Albert Einstein
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
- Child
- Adult
- Older Adult
Accepts Healthy Volunteers
No
Genders Eligible for Study
All
Description
Inclusion Criteria:
- critical lower limb ischemia resulting from arterial disease morphology TASC A or B or abdominal aortic aneurysms with correction indication
- Agreement and signing the informed consent.
Exclusion Criteria:
- exhibited severe chronic obstructive pulmonary disease (COPD)
- kidney failure
- heart failure
- pregnancy
- TASC C or D lesions
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Primary Purpose: Treatment
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: Single
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
Experimental: lower limb angioplasty with CO2
lower limb angioplasty made with carbon dioxide as contrast media
|
carbon dioxide (CO2) as arterial contrast media
|
|
Active Comparator: lower limb angioplasty with Iodine
lower limb angioplasty made with Iodine as contrast media
|
Iodine as arterial contrast media
|
|
Experimental: aorto-iliac angioplasty with CO2
aorto-iliac angioplasty made with carbon dioxide as contrast media
|
carbon dioxide (CO2) as arterial contrast media
|
|
Active Comparator: aorto-iliac angioplasty with Iodine
aorto-iliac angioplasty made with Iodine as contrast media
|
Iodine as arterial contrast media
|
|
Experimental: endovascular AAA correction with CO2
endovascular abdominal aortic aneurysm (AAA) correction made with carbon dioxide as contrast media
|
carbon dioxide (CO2) as arterial contrast media
|
|
Active Comparator: endovascular AAA correction with Iodine
endovascular abdominal aortic aneurysm (AAA) correction made with Iodine as contrast media
|
Iodine as arterial contrast media
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Contrastation analysis of the arterial lumen on endovascular procedures using CO2 as contrast media.
Time Frame: within 2 weeks of the procedure done we will analyze the quality of the images with CO2 and iodine contrast
|
image evaluated ranging from 1 (poor -when there was significant loss of definition in the vessels and/or collateral circulation which precluded the procedure), 2 (fair - when there was some loss of definition in the vessels and/or collateral circulation but not impossible to perform the procedure) and 3 (good - when there was good contrast in the vessels and collateral circulation).
|
within 2 weeks of the procedure done we will analyze the quality of the images with CO2 and iodine contrast
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
clinical outcome: changes in the post-surgery ABI
Time Frame: within 24h of the procedure
|
Identify changes in ankle-braquial index (ABI) after the procedures
|
within 24h of the procedure
|
Other Outcome Measures
Outcome Measure |
Time Frame |
|---|---|
|
post surgery creatinin clearance measure by the Cockcroft and Gault equation
Time Frame: within 30 days of the procedure
|
within 30 days of the procedure
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Sponsor
Collaborators
Investigators
- Principal Investigator: Nelson Wolosker, Hospital Israelita Albert Einstein
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start
April 1, 2012
Primary Completion (Actual)
July 1, 2014
Study Completion (Anticipated)
May 1, 2018
Study Registration Dates
First Submitted
February 26, 2013
First Submitted That Met QC Criteria
May 21, 2013
First Posted (Estimate)
May 23, 2013
Study Record Updates
Last Update Posted (Actual)
February 24, 2017
Last Update Submitted That Met QC Criteria
February 23, 2017
Last Verified
February 1, 2017
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- CO2
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Abdominal Aortic Aneurysms
-
Steven MaximusBaylor College of MedicineRecruitingAbdominal Aortic Aneurysms | Pararenal Aortic Aneurysm | Thoracoabdominal AneurysmsUnited States
-
Cook Research IncorporatedCompletedAbdominal Aortic Aneurysms | Iliac Aneurysms | Aortoiliac AneurysmsUnited States, Canada
-
Cook Group IncorporatedNo longer availableAbdominal Aortic Aneurysms | Aorto-iliac Aneurysms | Iliac AneurysmsUnited States
-
Cook Group IncorporatedApproved for marketingAbdominal Aortic Aneurysms | Aorto-iliac Aneurysms | Juxtarenal AneurysmsUnited States
-
Cook Group IncorporatedCompletedAbdominal Aortic Aneurysms | Aorto-iliac Aneurysms | Iliac AneurysmsUnited States, China, Germany, Sweden, Russian Federation
-
Cook Group IncorporatedCompletedAbdominal Aortic Aneurysms | Aorto-iliac Aneurysms | Juxtarenal AneurysmsUnited States
-
Prouse GiorgioRecruitingComplex Abdominal Aortic AneurysmsSwitzerland
-
Endospan Ltd.CompletedAortoiliac Aneurysms | Infrarenal Abdominal Aortic AneurysmsItaly, Serbia, Netherlands, Switzerland
-
iVascular S.L.U.RecruitingComplex Abdominal Aortic AneurysmsGermany, Belgium, Netherlands, France, Spain
-
Rijnstate HospitalW.L.Gore & AssociatesCompletedAneurysm | Abdominal Aortic Aneurysms | Common Iliac AneurysmsItaly, New Zealand, Netherlands, Spain
Clinical Trials on CO2
-
Brigham and Women's HospitalRecruiting
-
Cardiochirurgia E.H.Completed
-
Karolinska University HospitalCompleted
-
The University of Texas Health Science Center,...Recruiting
-
Assiut UniversityNot yet recruitingAtrophic Scar
-
Leiden University Medical CenterMerck Sharp & Dohme LLCCompletedProstate Cancer | Renal CancerNetherlands
-
Baylor Research InstituteNot yet recruiting
-
University of CalgaryNot yet recruiting
-
US Department of Veterans AffairsCompleted
-
Combined Military Hospital AbbottabadCompleted